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Lichen sclerosus (LS) is a chronic, inflammatory, 
mucocutaneous disorder of genital and extragenital 
skin (1). Simultaneous involvement of the oral mu-
cosa is extremely rare, but it may be the only affected 
area (2). 
A 55-year-old woman was referred to the Depart-
ment of Oral Medicine, School of Dental Medicine 
University of Zagreb due to whitish lesions on the 
right ventrolateral part of the tongue and buccal mu-
cosa with desquamative gingivitis (Figure 1, a-c). The 
lesions were asymptomatic but indurated on palpa-
tion. Histology was conclusive for oral lichen sclero-
sus (OLS). The lesions on gingiva were successfully 
treated with betamethasone ointment, three times a 
day for two weeks.
One year earlier, she had been referred to the 
Department of Dermatology and Venereology with 
progressive pruritus and dyspareunia, white patches, 
obliteration of the labia minora, and stenosis of the 
introitus (Figure 2). Histology was conclusive for vul-
var LS (Figure 3, a and b). She was successfully treated 
for 5 months with clobetasol propionate 0.05% oint-
ment. The patient was taking levothyroxine to treat 
hypothyroidism associated with Hashimoto’s thyroid-
itis and was otherwise healthy. 
Oral LS is clinically characterized by the appear-
ance of white macules, papules, or plaques mostly 
appearing on labial mucosa but also on buccal, pal-
ate mucosa and on the lower lip (2,3). On the geni-
tals, it typically manifests as atrophic white plaques, 
which may be accompanied by purpura or fissuring 
(1). While vulvar LS is often associated with pruritus, 
dyspareunia, and dysuria, OLS is often asymptomatic, 
although pain, soreness, pruritus, and tightness when 
opening the mouth can be present (1,2). Oral mani-
festations of LS, as well as association of anogenital 
and oral LS, are rarely reported in the literature (4-6). 
Tomo et al. searched the Medline database for papers 
reporting oral LS cases with histological diagnosis 
confirmation from 1957 to 2016 and found only 34 
cases of oral LS with histopathologic confirmation of 
the diagnosis (4). Kakko et al. reported 39 histologi-
cally proven cases of OLS (2). Attilli et al. (5) reviewed 
Figure 1a. Whitish lesions on the ventrolateral part of the 
tongue in patient with lichen sclerosus
Figure 1b. Whitish lesions of the buccal mucosa in patient 
with lichen sclerosus
Figure 1c. Desquamative gingivitis in upper jaw in patient 
with lichen sclerosus
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the clinical and histologic features of 72 cases of LS 
with oral/genital involvement. They reported that LS 
was diagnosed with exclusive genital lesions in 45, 
exclusive lip involvement in 20, and orogenital in-
volvement in only 7 cases (5). 
Some believe that many cases of clinically diag-
nosed lichen planus may actually be LS and that iso-
lated oral mucosal LS may not be as rare as is gener-
ally thought (2). While vulvar LS can occur at any age 
with increasing incidence with age, the median age 
of patients with OLS was 34 years and most of the pa-
tients were female (1,2,5). 
Due to the small number of patients in the litera-
ture, treatment recommendations for OLS are not 
available. In case of symptomatic oral lesions, topi-
cal or intralesional corticosteroids are considered to 
be the first-line treatment (2). First-line treatment for 
anogenital LS is a potent to very potent topical cor-
ticosteroid ointment, and second-line therapies in-
clude topical calcineurin inhibitors 1% pimecrolimus 
and 0.1% and 0.03% tacrolimus (1). For treatment-re-
sistant genital LS, oral retinoids, methotrexate, and 
possibly local steroid injections for single lesions are 
mainly applicable for women (1). There is limited evi-
dence for systemic treatments for both conditions. 
If it is not treated, genital LS is associated with 
a greater degree of scarring and an elevated risk of 
progression to squamous cell cancer; however, ma-
lignant transformation of OLS has not been reported 
(1-6).
Due to the very rare presentation in the oral cav-
ity, it is important to notice these lesions during a 
dental exam.
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Figure 3a and 3b. Hyperkeratotic stratified squamous epi-
thelium, partly normal thickness, partly with evidence of 
thinning, and with loss of the normal rete ridge. The strati-
fied squamous epithelium shows hydropic degeneration of 
basal and parabasal cells in few areas. The subjacent con-
nective tissue showed dense linear subepithelial inflamma-
tory cell infiltrate. (Hematoxylin and eosin, 10x and 40x)
Figure 2. White patches, obliteration of the labia minora 
and stenosis of the introitus in 55-year old patients with 
vulvar lichen sclerosus
197ACTA DERMATOVENEROLOGICA CROATICA
5. Attili VR, Attili SK. Lichen sclerosus of lips: a clinical 
and histopathologic study of 27 cases. Int J Der-
matol. 2010;49:520-5.
6. Louvain D, Moura Jacques C, Fernandes Ferreira A, 
Hoehl Carneiro L, Quintela L, Cuzzi T, et al. Lichen 
sclerosus in the oral mucosa: a rare form of presen-
tation. Acta Dermatovenerol Croat. 2012;20:43-7.
Vanja Vučićević Boras 1,2, Ivana Škrinjar2, 
Lovorka Batelja Vuletić3, Mirna Bradamante4, 
Igor Bartenjev5, Suzana Ljubojević Hadžavdić4
1Department of Oral Medicine, School of Dental 
Medicine, University of Zagreb, Zagreb, Croatia 
2Department of Oral Medicine, University Hospital 
Center Zagreb, Zagreb, Croatia
3Department of Pathology, University Hospital 
Center Zagreb, University of Zagreb School of Medicine, 
Zagreb, Croatia
4Department of Dermatology and Venereology, 
University Hospital Center Zagreb, University of Zagreb 
School of Medicine, Zagreb, Croatia
5Department of Dermatovenerology, Medical 
faculty, University of Ljubljana, Ljubljana, Slovenia
Corresponding author:
Ivana Škrinjar, MD






Received: November 30, 2018
Accepted: Augist 7, 2019
Letter to the editor Acta Dermatovenerol Croat
    2019;27(3):195-197
